Standard Biotools (LAB) Cash from Investing Activities (QoQ) (2010 - 2026)
Standard Biotools (LAB) Cash from Investing Activities (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.90 Bn | 193.29 Bn | 7.27 Bn |
| 2 | Stryker | 129.12 Bn | 125.64 Bn | 4.50 Bn |
| 3 | Medtronic | 119.32 Bn | 110.10 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.63 Bn | 73.09 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.14 Bn | 47.89 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.54 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.06 Bn | 31.95 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn |
| 10 | Standard Biotools | 254.42 Mn | -222.29 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -92.46% |
| Mar 31, 2026 | 2,476.74% |
| Dec 31, 2025 | -20.34% |
| Sep 30, 2025 | -124.29% |
| Jun 30, 2025 | 88.07% |
| Mar 31, 2025 | -43.15% |
| Dec 31, 2024 | 183.30% |
| Sep 30, 2024 | -161.45% |
| Jun 30, 2024 | -84.20% |
| Mar 31, 2024 | 2,524.91% |
| Dec 31, 2023 | 73.73% |
| Sep 30, 2023 | -224.42% |
| Jun 30, 2023 | -7.02% |
| Mar 31, 2023 | 7.23% |
| Dec 31, 2022 | 274.86% |
| Sep 30, 2022 | 107.77% |
| Jun 30, 2022 | -15,826.27% |
| Sep 30, 2021 | -18.76% |
| Jun 30, 2021 | -84.75% |
| Mar 31, 2021 | -498.91% |